A detailed history of Bromfield Sneider Wealth Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Bromfield Sneider Wealth Advisors holds 895 shares of PFE stock, worth $25,140. This represents 0.01% of its overall portfolio holdings.

Number of Shares
895
Previous 895 -0.0%
Holding current value
$25,140
Previous $25,000 4.0%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 06, 2022

SELL
$46.53 - $55.17 $48,949 - $58,038
-1,052 Reduced 54.03%
895 $47,000
Q1 2022

Apr 12, 2022

BUY
$45.75 - $56.69 $89,075 - $110,375
1,947 New
1,947 $101,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $158B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bromfield Sneider Wealth Advisors Portfolio

Follow Bromfield Sneider Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bromfield Sneider Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bromfield Sneider Wealth Advisors with notifications on news.